Brigham and Women’s Hospital Board Review

A broad approach to key topics in endocrinology with special focus on board certification and recertification. Ideal for MOC.

QUICK FACTS

Provider: Brigham and Women’s Hospital

Course Director:
Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc
Assistant Professor of Medicine
Harvard Medical School
Division of Endocrinology, Diabetes and Hypertension
Department of Medicine
Brigham and Women’s Hospital

Course Director:
The Brigham Board Review
Distance Learning Series
Ajay K. Singh, MBBS, FRCP (UK), MBA
Senior Associate Dean for Global and
Continuing Education
Director, Master in Medical Sciences in
Clinical Investigation (MMSCI) Program
Harvard Medical School
Director, Office of
Postgraduate Medical Education
Brigham and Women’s Hospital

CME Board Review in Endocrinology

This CME program is a wide-ranging review of the essential topics in endocrinology. The Brigham Board Review in Endocrinology includes case-based lectures on topics like type 1 and type 2 diabetes, antidiabetic agents, diabetic emergencies, pituitary and hypothalamic disorders, adrenal disorders, etc. It will help you to:

• Prepare for the American Board of Internal Medicine (ABIM) Endocrinology certification and recertification examinations
• Demonstrate improved understanding of endocrine diseases
• Correlate pathophysiology and pathobiology with clinical presentations
• Evaluate the latest therapeutic strategies with risks and benefits
• Attain the latest knowledge for management of diabetes, obesity, osteoporosis, menopausal symptoms, gender dysphoria, etc.
• Apply new information to your daily practice, improving diagnostic accuracy and patient management

TOPICS

Diabetes Mellitus and Hypoglycemia: Overview of Diabetes

• Type 2 Diabetes Mellitus: Screening, Diagnosis and Prevention – Marie E. McDonnell, MD

• Type 1 Diabetes Mellitus – Margo S. Hudson, MD

Diabetes Mellitus and Hypoglycemia: Management of Hyperglycemia

• Lifestyle Modification in Diabetes Management – Marie E. McDonnell, MD

• Antidiabetic Agents 1: Metformin, Sulfonylureas, Meglitinides and Thiazolidinediones – Amir M. Tirosh, MD, PhD

• Antidiabetic Agents 2: GLP-1 and SGLT-2: New Approaches to Type 2 Diabetes – Margo S. Hudson, MD

• Antidiabetic Agents 3: Insulin – Alexander Turchin, MD, MS
  

• Selecting Antidiabetic Therapy – Marie E. McDonnell, MD

• Assessing Glycemic Control in Type 2 Diabetes – Alexander Turchin, MD, MS
  

• Inpatient Hyperglycemia: Evidence-Based Approaches and Treatment Strategies – Nadine E. Palermo, DO

• Hyperglycemic Crisis: Diagnosis, Management and Transition of Care – Nadine E. Palermo, DO

• Diabetes in Pregnancy – Marie E. McDonnell, MD

Diabetes Mellitus and Hypoglycemia: Chronic Complications of Diabetes

• Cardiovascular Risk Reduction in Diabetes – Bindu Chamarthi, MD, MMSc

• Microvascular and Dermatologic Complications of Diabetes – Margo S. Hudson, MD

Lipids, Obesity and Nutrition

• Evaluation and Management of Obesity – Florencia Halperin, MD

• Assessment and Treatment of Dyslipidemia – Jorge Plutzky, MD

Thyroid Disorders

• Hypothyroidism – Trevor E. Angell, MD

• Hyperthyroidism and Thyroiditis – Matthew I. Kim, MD

• Thyroid Nodules – Ellen Marqusee, MD

• Improving Thyroid Nodule Care with Molecular Diagnostics – Preoperative Assessment – Erik K. Alexander, MD

• Thyroid Cancers – Trevor E. Angell, MD

Calcium and Bone Disorders

• Evaluation of the Patient with Low Bone Density – Sharon H. Chou, MD

• Treatment of Osteoporosis – Sharon H. Chou, MD

• Hypercalcemia – J. Carl Pallais, MD

• Hypocalcemia – J. Carl Pallais, MD

• Topics in Metabolic Bone Disease – Eva S. Liu, MD

• Calcium and Bone Cases for the Boards – Carolyn B. Becker, MD

Pituitary and Hypothalamic Disorders

• Anterior and Posterior Pituitary Insufficiency – Le Min, MD, PhD

• Pituitary Masses – Ursula B. Kaiser, MD

• Prolactin and Growth Hormone Excess – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc

• Neuroendocrine Cases for the Boards – Ursula B. Kaiser, MD

Adrenal Disorders

• Primary and Secondary Adrenal Insufficiency – Jonathan S. Williams, MD, MMSc

• Diagnosis and Treatment of Cushing’s Syndrome – Gail K. Adler, MD, PhD

• Primary Hypertension – Naomi D. Fisher, MD

• Endocrine Hypertension – Naomi D. Fisher, MD

• Adrenal Nodules and Cancer – Anand Vaidya, MD, MMSc

• Update on Pheochromocytomas and Paragangliomas – Anand Vaidya, MD, MMSc

• Adrenal Cases for the Boards – Anand Vaidya, MD, MMSc

Reproductive Endocrinology

• Evaluation of the Patient with Menstrual Irregularities – Maria A. Yialamas, MD

• Management of Menopausal Symptoms – Ole-Petter R. Hamnvik MB, BCh, BAO, MMSc

• Contraception Overview and Use in Women with Endocrine Disease – Caryn R. Dutton, MD

• Polycystic Ovarian Syndrome and Approach to Female Androgen Excess Disorders – Grace Huang, MD

• Infertility and Assisted Reproduction – Janis H. Fox, MD

Male Reproduction

• Erectile and Ejaculatory Disorders – Michael P. O’Leary, MD

• Male Reproductive Endocrine Cases for the Boards – J. Carl Pallais, MD

Genetics in Endocrinology

• Hereditary Syndromes in Endocrinology: Genetics and Management – Adi Barlev-Ehrenberg, MD, MS

• Gender Dysphoria and Medical Management of the Transgender Patient – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc

• Hypoglycemia in Non-Diabetic Patients: Diagnosis and Management – Rajesh K. Garg, MD

• Carcinoid and Pancreatic Neuroendocrine Tumors – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc

Learning Objectives

After viewing this activity, participants should be able to affirm or modify their approach to patient management in the following areas:

• Summarize and demonstrate increased overall knowledge of endocrine diseases
• Identify and improve knowledge and clinical competence-based practice gaps in endocrinology
• Correlate pathophysiology and pathobiologic principles with clinical presentations
• Describe optimal therapeutic strategies and their risks and benefits
• Apply the knowledge and strategies gained through participation in this activity to the board exam and daily practice

Intended Audience

This activity was designed for fellows/trainees and practicing endocrinologists and other professional affiliates (internists with an interest in endocrinology) who are preparing to take ABIM Board Review or Recertification Examinations or who seek CME in attempt to improve patient care.

Date of Original Release: December 31, 2016
Credit Expiration Date: December 31, 2019
Contact Hours: 33.25